Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 131 genetic loci highlight immunological pathways and tissues in nasal polyposis and asthma1 passage
• A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial1 passage
• A genome-wide meta-analysis identifies 50 genetic loci associated with carpal tunnel syndrome1 passage
• A legume-enriched diet improves metabolic health in prediabetes mediated through gut microbiome: a randomized controlled trial1 passage
• AI-enabled electrocardiogram alert for potassium imbalance treatment: a pragmatic randomized controlled trial1 passage
• Agricultural land-uses consistently exacerbate infectious disease risks in Southeast Asia1 passage
• An investigation of causal relationships between prediabetes and vascular complications1 passage
• Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes1 passage
• Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation1 passage
• Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial1 passage
• Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial1 passage
• Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases1 passage
• Genome-wide association meta-analysis yields 20 loci associated with gallstone disease1 passage
• Gut microbiome predicts personalized responses to dietary fiber in prediabetes: a randomized, open-label trial1 passage
• HRS-7535, an oral small-molecule GLP-1 receptor agonist, in Chinese adults with obesity without diabetes: a randomized, double-blind, placebo-controlled phase 2 trial1 passage
• Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children1 passage
• Large-scale cross-ancestry genome-wide meta-analysis of serum urate1 passage
• Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence1 passage
• Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma1 passage
• Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials1 passage
• Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial1 passage
• Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children1 passage
• Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children1 passage
• Pharmacokinetics, bactericidal activity and toxicity of short oral regimens for rifampicin-resistant tuberculosis treatment1 passage
• Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma1 passage
• Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial1 passage
• Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers1 passage
• Timing of unsaturated fat intake improves insulin sensitivity via the gut microbiota-bile acid axis: a randomized controlled trial1 passage
• Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial1 passage